Energy Transfer is a midstream leader with an especially juicy distribution.
Pfizer is committed to maintaining its dividend.
Verizon has increased its dividend for 20 consecutive years.
"It takes money to make money."
You've probably heard that statement many times. And it's usually true. However, some assets allow you to make more money with less money.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
For example, investing $10,000 in the S&P 500 (SNPINDEX: ^GSPC) would generate only about $100 in annual dividend income. However, spreading that same amount across three stocks -- Energy Transfer (NYSE: ET), Pfizer (NYSE: PFE), and Verizon Communications (NYSE: VZ) could generate over $634 in annual income.
Image source: Getty Images.
Energy Transfer, Pfizer, and Verizon are all high-yield dividend stocks. The math is simple: Investing $10,000 in the three stocks can enable you to rake in over $634 in dividends over the next 12 months.
Pfizer's forward dividend yield is currently 6.12%. Buying $3,333 (roughly one-third of your initial $10,000) worth of the drugmaker's shares should equate to around $204 in annual dividend income.
Verizon's yield of 6.15% is only slightly higher than Pfizer's. Investing $3,333 in the communication services stock would give you around $205 in dividend income over the next year.
Your passive income would be even higher with Energy Transfer. Thanks to the midstream limited partnership's juicy 6.77% yield, you could earn over $225 in annual distributions. That brings our total to above $634.
I suspect the actual income you could make with these stocks would be even higher, though. Energy Transfer expects to grow its distribution by 3% to 5% per year. Verizon has increased its dividend for 20 consecutive years. I predict that streak will continue in 2027.
What about Pfizer? The big pharma company probably won't increase its dividend. However, I don't think the dividend is in jeopardy of being cut. CEO Albert Bourla said in the 2026 second-quarter earnings conference call, "We feel extremely confident that we will -- even in the most stretched scenarios that we are running, we will be able to maintain our dividend."
I'm confident that investors will receive at least $634 in dividend income by investing $10,000 in Energy Transfer, Pfizer, and Verizon. There is a potential fly in the ointment, though: It's possible that stock declines could wipe out any dividend income made over the next 12 months.
An economic downturn could negatively impact Energy Transfer and Verizon. Higher interest rates could especially hurt Verizon because of its debt load. Pfizer faces a patent cliff with several top-selling drugs losing patent exclusivity over the next couple of years.
That said, I think all three stocks should perform well over the long term. And I expect they will continue to generate significant income for investors.
Before you buy stock in Verizon Communications, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Verizon Communications wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $361,650!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,437,517!*
Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 5, 2026.
Keith Speights has positions in Energy Transfer, Pfizer, and Verizon Communications. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Verizon Communications. The Motley Fool has a disclosure policy.